16:18 EDT Unicycive Therapeutics (UNCY) files $150M mixed securities shelfClaim 55% Off TipRanksUnlock trusted, data-backed investing tools with...
Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on UNCY:Disclaimer & DisclosureReport an Issue
Unicycive Therapeutics price target raised to $18 from $15 at Benchmark
Improving web traffic and cost-cutting measures could boost shares of Peloton higher from here, according to UBS.
We're taking half of the cash raised from the sale to add to one of the portfolio's recent spinoffs.
UBS analyst Kevin Caliendo's revised price target implies 15% upside ahead for shares of the health care benefit and pharmacy…
The investment bank upgraded the pharmaceutical name to buy from neutral.
The bank pointed to recent M&A success as a catalyst for the stock.
The investment firm initiated coverage of the biopharma stock at a outperform rating.
